Pipeline Session

[P1] Specialty Pharmaceuticals in Development

ACPE UAN: 0233-0000-19-023-L04-P | Contact Hours: 1.25 | Activity Type: Knowledge-based

Faculty(s)

• 

  Aimee Tharaldson, PharmD

  Senior Clinical Consultant, Emerging Therapeutics
  Express Scripts
  Woodbury, Minnesota

Moderator(s)

• JS

  Joan Siegel, MSPharm

  Corporate Accounts- Managed markets
  CSL Behring
  King of Prussia, Pennsylvania

Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs. It is anticipated that this trend will continue. How will these specialty medications affect the dynamic health care landscape and managed care pharmacy?

This pipeline session will focus on new and emerging specialty medications and explore their likely role in therapy. This session will also discuss the potential impact of these agents on the managed care market.

Learning Objectives:

At the completion of this activity, participants should be able to:

1. Recognize recently approved specialty medications.
2. Identify specialty medications that are likely to be approved in the next 12 months.
3. Discuss the mechanism of action, indications, efficacy, and safety of new and emerging specialty medications.
4. Report the likely effect of new specialty medications on the managed care market.